Richard T. Clark, chairman, president and chief executive officer of Merck & Co. Inc. announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co. Inc. and Schering-Plough Corporation.
According to the Merck press release, Animal Health and Consumer Health Care will operate as separate business units reporting to Clark.
Raul E. Kohan, currently senior vice president and president of Intervet Schering-Plough Animal Health, will lead the new Merck's animal health business. Kohan will report to Clark and serve on the executive committee.
While most of the current Merck executive leadership will remain intact, at least nine of the 13 members of the executive committee will come from Merck. About 40 percent of Schering-Plough's senior leaders will be part of the newly combined company. A substantial majority of Schering-Plough employees will remain with the combined company.
Schering-Plough's Animal Health business is a world leader with market-leading products for a broad range of species and strong growth potential. The division has more than 1,000 marketed products and generates approximately $3 billion in revenues from business operations in more than 140 countries, according to the release.